LEADER 00692nam0-22002771i-450- 001 990003504880403321 005 20001010 035 $a000350488 035 $aFED01000350488 035 $a(Aleph)000350488FED01 035 $a000350488 100 $a20000920d1916----km-y0itay50------ba 101 0 $aita 105 $ay-------001yy 200 1 $a<>evolution of Coinage 210 $a$c$d1916 225 1 $a 700 1$aMacDonald,$bGeorge$f<1862-1940>$0186754 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990003504880403321 952 $aSE 084.07.02-$b66$fDECSE 959 $aDECSE 996 $aEvolution of Coinage$9497381 997 $aUNINA DB $aING01 LEADER 01081nam0 22002651i 450 001 RML0233863 005 20231121125700.0 100 $a20121121d1986 ||||0itac50 ba 101 | $aita 102 $ait 181 1$6z01$ai $bxxxe 182 1$6z01$an 200 1 $aDiritto alla riservatezza e diritto al segreto nel rapporto di lavoro$eLa disciplina giuridica della circolazione delle informazioni nell'impresa$fPietro Ichino 205 $aRistampa inalterata 210 $aMilano $cGiuffr $d1986 215 $aiv,317 p.$d25 cm. 700 1$aICHINO$b, Pietro$3RMLV148035$0124630 801 3$aIT$bIT-01$c20121121 850 $aIT-FR0098 899 $aBiblioteca Area Giuridico Economica$bFR0098 912 $aRML0233863 950 0$aBiblioteca Area Giuridico Economica$d 53IMP 344.01/36$e 53VM 0000021555 VM barcode:ECO004559. - Inventario:291. - Fondo:Sala consultazioneVM$fA $h19951005$i20121204 977 $a 53 996 $aDiritto alla riservatezza e diritto al segreto nel rapporto di lavoro$9617448 997 $aUNICAS LEADER 03092nam 22006615 450 001 9910300190803321 005 20200701021422.0 010 $a1-907673-76-8 024 7 $a10.1007/978-1-907673-76-4 035 $a(CKB)3710000000280765 035 $a(EBL)1965086 035 $a(OCoLC)908083154 035 $a(SSID)ssj0001386383 035 $a(PQKBManifestationID)11814649 035 $a(PQKBTitleCode)TC0001386383 035 $a(PQKBWorkID)11374306 035 $a(PQKB)11089443 035 $a(DE-He213)978-1-907673-76-4 035 $a(MiAaPQ)EBC1965086 035 $a(PPN)183086295 035 $a(EXLCZ)993710000000280765 100 $a20141112d2015 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aCancer-Related Fatigue /$fby Joachim Weis, Markus Horneber 205 $a1st ed. 2015. 210 1$aTarporley :$cSpringer Healthcare Ltd. :$cImprint: Springer Healthcare,$d2015. 215 $aVII, 74 s 300 $aDescription based upon print version of record. 311 $a9781907673764 311 $a1-907673-75-X 320 $aIncludes bibliographical references at the end of each chapters. 327 $aIntroduction -- Etiology and pathogenetic factors -- Nonpharmacological treatment of cancer-related fatigue -- Pharmacological treatment of cancer-related fatigue -- Recommendations for the management of cancer-related fatigue. 330 $aCancer-related fatigue (CrF) is increasingly recognized as a signi?cant problem for patients with cancer at all stages, including those undergoing therapy and in remission. In fact, studies have shown that CrF causes patients more distress than pain, nausea, or vomiting and yet fatigue is still often undertreated and rarely studied. However, several new treatments such as are being investigated to determine the most effective ways to manage this debilitating symptom and improve patient quality of life. Cancer-Related Fatigue will provide a concise overview of this condition, with an evidence-based discussion of diagnosis, treatment, and long-term management. 606 $aMedicine 606 $aOncology 606 $aInternal medicine 606 $aMedicine/Public Health, general$3https://scigraph.springernature.com/ontologies/product-market-codes/H00007 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 606 $aInternal Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H33002 615 0$aMedicine. 615 0$aOncology. 615 0$aInternal medicine. 615 14$aMedicine/Public Health, general. 615 24$aOncology. 615 24$aInternal Medicine. 676 $a610 676 $a616 676 $a616994 700 $aWeis$b Joachim$4aut$4http://id.loc.gov/vocabulary/relators/aut$0789319 702 $aHorneber$b Markus$4aut$4http://id.loc.gov/vocabulary/relators/aut 906 $aBOOK 912 $a9910300190803321 996 $aCancer-Related Fatigue$92522511 997 $aUNINA